Acorda Therapeutics Release: First Study of Diazepam Nasal Spray in...

... of Dosing During Seizure Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced results of the first clinical study to ...

http://www.biospace.com/news_story.aspx?StoryID=301195&full=1